Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial
ConclusionThe combination of Naoxintong Capsule with standard care reduced the 2-year stroke recurrence rate in patients with ischemic stroke without increasing the risk of severe hemorrhage in high-risk patients. (Trial registration No. NCT02334969)
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Bleeding | China Health | Heart Attack | Hemorrhagic Stroke | Internal Medicine | Ischemic Stroke | Stroke | Subarachnoid Hemorrhage